Wikidata

(Q45014818)

English

Phase II study to investigate the ablative efficacy of intravesical administration of gemcitabine in intermediate-risk superficial bladder cancer (SBC).

scientific article

In more languages

Statements

title
Phase II study to investigate the ablative efficacy of intravesical administration of gemcitabine in intermediate-risk superficial bladder cancer (SBC). (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
15306105
retrieved
8 December 2017
author name string
Giovanni Casetta
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
15306105
retrieved
8 December 2017
Gloria Maso
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
15306105
retrieved
8 December 2017
Filippo Sogni
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
15306105
retrieved
8 December 2017
Giuliano Pretti
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
15306105
retrieved
8 December 2017
Andrea Zitella
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
15306105
retrieved
8 December 2017
Alessandro Tizzani
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
15306105
retrieved
8 December 2017
publication date
1 September 2004
1 reference
stated in
Europe PubMed Central
PubMed ID
15306105
retrieved
8 December 2017
page(s)
339-343
1 reference
stated in
Europe PubMed Central
PubMed ID
15306105
retrieved
8 December 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q45014818&oldid=1523409978"